Joint Action on Tobacco Control 2

JATC2 started in 2021 and will run until 2024. 

RIVM participates in several work packages and leads work package 9 (WP9): Additives Subject to Enhanced Reporting Obligations. WP9 is aimed at investigating the health impact and regulatory implications of e-cigarettes and novel tobacco products. The outcomes are expected in 2024.


JATC2 is co-funded by the European Union’s Health Programme under Grant Agreement No. 101035968/ JA-01-2020.